2 February 2012
Last updated at 00:01
By Smitha Mundasad
BBC News
Abiraterone has been shown to extend life for more than three months
A drug that can extend the life of men with advanced prostate cancer by more than three months has provisionally been rejected for NHS use.
Draft guidance from the health watchdog for England and
No comments:
Post a Comment